Search
for
Sort by
Research 61–90 of 218
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- Research progress of post-acute sequelae after SARS-CoV-2 infection
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Long-Term Effects of COVID-19
- Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study
- Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity
- Dermatological manifestations of COVID-19 and its therapies: a review
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis
- Can the golden nutraceutical frankincense combat COVID‐19?
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- New substrates for stem cell control
- Comparison of Complications after Coronavirus Disease and Seasonal Influenza, South Korea
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels